James David Clark is VP at CVS HEALTH Corp (CVS). They have made 8 open-market trades across 1 company since 2019, most recently 2026-06-26.
CIK 0001757584
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CVS | 27,606 | $2.2M |
Shares reported on the most recent Form 4, priced at the 2026-06-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CVS | SELL | 2025-03-05 | 2025-03-07 | $66.35 | $997K | +3.4% | -2.8% | -4.0% |
| CVS | SELL | 2023-08-03 | 2023-08-04 | $74.93 | $3.9M | -0.4% | -10.1% | -4.6% |
| CVS | SELL | 2022-01-28 | 2022-02-01 | $109.00 | $660K | -1.5% | -1.2% | -8.8% |
| CVS | SELL | 2021-03-31 | 2021-04-01 | $76.00 | $407K | +1.2% | +4.7% | +12.5% |
| CVS | SELL · 10b5-1 | 2020-05-26 | 2020-05-28 | $65.00 | $18K | +4.5% | -3.0% | -5.6% |
| CVS | SELL | 2020-04-28 | 2020-04-30 | $65.00 | $405K | +4.2% | +8.0% | +5.6% |
| CVS | SELL | 2020-03-30 | 2020-04-01 | $60.00 | $182K | +8.5% | +5.2% | +14.5% |
| CVS | SELL | 2019-03-01 | 2019-03-01 | $58.14 | $97K | -3.1% | -7.2% | -9.6% |
| CVS | SELL | 2019-03-01 | 2019-03-01 | $58.14 | $97K | -3.1% | -7.2% | -9.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.